Brief: Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility
Today 02:27
BRIEF-Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility June 29 (Reuters) - BCAL Diagnostics Ltd BDX.AX:
SECURES A$4.9 MILLION UNDER CONVERTIBLE NOTE FACILITY
EXPECTS REMAINING FY26 RD TAX OFFSET IN OCTOBER 2026
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsBrief: Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility
Australia's BCAL Diagnostics soars on development of new blood test for breast cancer
Brief: BCAL Diagnostics Says Validation Agreement Signed With Sonic USA, For Breastest V2
Australia's BCAL Diagnostics launches early detection cancer platform, shares rise
Brief: BCAL Diagnostics Launches Early Detection Cancer Platform